NCT02669355 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

de Klerk E, van der Heijde D, Landewé R, van der Tempel H, van der Linden S
The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. J Rheumatol. 2003 Nov;30(11):2469-75.
Fernandes E
Doctors and medical students in India should stop wearing white coats. BMJ. 2015 Jul 21;351:h3855. doi: 10.1136/bmj.h3855.
Hughes LD, Done J, Young A
A 5 item version of the Compliance Questionnaire for Rheumatology (CQR5) successfully identifies low adherence to DMARDs. BMC Musculoskelet Disord. 2013 Oct 8;14:286. doi: 10.1186/1471-2474-14-286.
Petrilli CM, Mack M, Petrilli JJ, Hickner A, Saint S, Chopra V
Understanding the role of physician attire on patient perceptions: a systematic review of the literature--targeting attire to improve likelihood of rapport (TAILOR) investigators. BMJ Open. 2015 Jan 19;5(1):e006578. doi: 10.1136/bmjopen-2014-006578. Review.

Observational Study to Determine the Effect of Wearing of White Coat on Patient Satisfaction in Indian Out Patient Department (OPD) Setting

Clinical trial NCT02669355 - References